MedTrace Logo

The Effectiveness of Conversational AI Service (chatbot) Utilization on Vaccine Confidence

NCT05424952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2024-12-06

No results posted yet for this study

Summary

The primary objective of this study is to develop and evaluate a conversational AI service (chatbot) on social media platforms to obtain accurate and up-to-date vaccine information, and assess the impact of chatbot usage on users' vaccine confidence and acceptance in Hong Kong, Singapore, and Thailand.

Conditions

  • Vaccination Hesitancy

Interventions

OTHER

Conversational AI Service (Chatbot)

WhatsApp or Messenger Chatbot for COVID-19 vaccines

Sponsors & Collaborators

  • National University of Singapore

    collaborator OTHER

  • Health Intervention and Technology Assessment Program (HITAP)

    collaborator UNKNOWN

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Joseph T Wu, PhD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-11
Primary Completion
2023-02-17
Completion
2023-02-17

Countries

  • Hong Kong
  • Singapore
  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05424952 on ClinicalTrials.gov